Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene

Journal of Investigative Dermatology

Volumn 113, Issue 5, 1999, Pages 782-787

  Kyriakides, Themis R ^a   Tam, Jessica W Y ^a   Bornstein, Paul ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Fibrillogenesis; Matricellular; Remodeling

Indexed keywords

COLLAGEN; SCLEROPROTEIN; THROMBOSPONDIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; EPITHELIZATION; EXCISION; EXTRACELLULAR MATRIX; GENE DISRUPTION; GRANULATION TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PUNCH BIOPSY; SKIN FIBROBLAST; WOUND HEALING;

EID: 0032707093     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00755.x     Document Type: Article

References (32)

1. Adams JC, Lawler J: Diverse mechanisms for cell attachment to platelet Thrombospondin. J Cell Sci 104:1061-1071, 1993
2. Barton SP, Abdullah MS, Marks R: Quantification of microvascular changes in the skin in patients with psoriasis. Br J Dermatol 126:569-574, 1992
3. Bornstein P: The thrombospondins: Structure and regulation of expression. FASEB J 6:3290-3299, 1992
4. Bornstein P: Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol 130:503-506, 1995
5. Bornstein P, Sage EH: Thrombospondins. Methods Enzymol 245:62-85, 1994
6. Clark RAF: Biology of dermal wound repair. Dermatol Clin 11:647-666, 1993
7. De Vries HJC, Zeegelaar JE, Middelkoop E, Van Gijsbers G, Marle J, Wildevuur CHR, Westerhof W: Reduced wound contraction and scar formation in punch biopsy wounds. Native collagen dermal substitutes. A clinical study. Br J Dermatol 132:690-697, 1995
8. DiPietro LA, Nissen NN, Gamelli RL, Koch AE, Pyle JM, Polverini PJ: Thrombospondin 1 synthesis and function in wound repair. Am J Pathol 148:1851-1860, 1996
9. Forsberg E, Hirsch E, Frohlich L, et al: Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc Natl Acad Sci USA 93:6594-6599, 1996
10. Frazier WA: Thrombospondins. Curr Opin Cell Biol 3:792-799, 1991
11. ffrench-Constant C, Van De Water L, Dvorak HF, Hynes RO. Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 109:903-914, 1989
12. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 87:6624-6628, 1990
13. Grinnell F: Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol 124:401-404, 1994
14. Gross J, Farinelli W, Sadow P, Anderson R, Bruns R: On the mechanism of skin wound 'contraction': a granulation tissue 'knockout' with a normal phenotype. Proc Natl Acad Sci USA 92:5982-5986, 1995
15. Iruela-Arispe ML, Liska DJ, Sage EH, Bornstein P: Differential expression of thrombospondin 1, 2 and 3 during murine development. Dev Dyn 197:40-56, 1993
16. Kyriakides TR, Zhu Y, Yang Z, Bornstein P: The distribution of the matricellular protein thrombospondin 2 in tissues of embryonic and adult mice. J Histochem Cytochem 46:1007-1015, 1998a
17. Kyriakides TR, Zhu Y, Smith LT, et al: Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 140:419-430, 1998b
18. Kyriakides TR, Leach KJ, Hoffman AS, Ratner BD, Bornstein P: Mice that lack the angiogenesis inhibitor, thrombospondin 2, mount an altered foreign body reaction characterized by increased vascularity. Proc Natl Acad Sci USA 13:4449-4454, 1999
19. Latijnhouwers MA, Van Bergers M, Bergen BH, Spruijt KI, Andriessen MP. Schalkwijk J: Tenascin expression during wound healing in human skin. J Pathol 178:30-35, 1996
20. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BLM: Altered wound healing in mice lacking a functional osteopontin gene (ssp1). J Clin Invest 101;1468-1478, 1998
21. Mackie EJ, Halfter W, Liverani D: Induction of tenascin in healing wounds. J Cell Biol 107:2757-2767, 1988
22. Moulin V, Castilloux G, Jean A, Garrel DR, Auger FA, Germain L: In vitro models to study wound healing fibroblasts. Burns 22:350-362, 1996
23. Mutsaers SE, Bishop JE, McGrouther G, Laurent GJ: Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol 29:5-17, 1997
24. Nodder S, Martin P: Wound healing in embryos: a review. Anat Embryol 195:215-228, 1997
25. Raugi GJ, Olerud JE, Gown AM: Thrombospondin in early human wound tissue. J Invest Dermatol 89:551-554, 1987
26. Subramaniam M, Saffaripour S, Van De Water L, Frenette PS, Mayadas TN, Hynes RO, Wagner DD: Role of endothelial selectins in wound repair. Am J Pathol 150:1701-1709, 1997
27. Tang L, Eaton JW: Inflammatory responses to biomaterials. Am J Clin Pathol 103:466-471, 1995
28. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N: Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 122:497-511, 1993
29. Tooney P, Sakai T, Sakai K. Aeschlimann D, Mosher D: Restricted localization of thrombospondin-2 protein during mouse embryogenesis: a comparison to thrombospondin 1. Matrix Biol 17:131-143, 1998
30. Volpert OV, Tolsma SS, Pellerin S, Feige J-J, Chen H, Mosher DF, Bouck N: Inhibition of angiogenesis by thrombospondin 2. Biochem Biophys Res Commun 217:326-332, 1995
31. Williams DF: A model for biocompatibility and its evaluation. J Biomed Eng 11:185-191, 1989
32. Woodward SC: How fibroblasts and giant cells encapsulate implants: considerations on design of glucose sensors. Diabetes Care 5:278-281, 1982